Research Papers

25 of 344 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Influence of the body positions adopted for resistance training on intraocular pressure: a comparison between the supin…
Lara PM; Redondo B; Jerez-Mayorga D; Martínez-García D; García-Ramos A; Vera J.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Impact of implementation of polymerase chain reaction on diagnosis, treatment, and clinical course of Acanthamoeba kera…
Roth M; Balasiu A; Daas L; Holtmann C; Servera A; Walckling M; MacKenzie CR; Fuchsluger TA; Geerling G.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Comitant strabismus etiology: extraocular muscle integrity and central nervous system involvement-a narrative review.
Sunyer-Grau B; Quevedo L; Rodríguez-Vallejo M; Argilés M.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Correlation between the ablation ratio and posterior corneal stability after small incision lenticule extraction for hi…
Yang L; Liu S; Zhou X; Zhao Y.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Central retina plays a decisive role in the suppression of pupillary escape.
Kelbsch C; Jendritza R; Strasser T; Tonagel F; Richter P; Jung R; Peters T; Wilhelm H; Wilhelm B; Stingl K.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Utility of isolated-check visual evoked potential technique in dysthyroid optic neuropathy.
Luo B; Liu R; Wang S; Hu W; Li Y; Tong B; Zhang H; Qi X.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Assessment of cataract surgery outcomes in Nampula (Mozambique): visual acuity, visual function and quality of life.
Sengo DB; Saravila PJ; Chivinde SS; Mate LM; Faquihe MF; Moragues R; López-Izquierdo I; Caballero P.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Automated macular segmentation can distinguish glaucomatous from compressive optic neuropathy.
Soares RM; Braga JF; da Silva Fernandes J; Ferreira CC; Ribeiro L; Alves H; Meira D.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Impact of intravitreal injection therapy on contrast sensitivity in patients with nAMD and DME.
Dieke S; Wurche S; Ruebsam A; Wirbelauer C; Joussen AM; Winterhalter S.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Impact of peripapillary staphylomas on the vascular and structural characteristics in myopic eyes: a propensity score m…
Nie F; Zhang L; Cao M; Zhou D; Liu K; Ouyang J; Luo L; Zhu R; Liu S; Duan X.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review.
Yeo S; Kim H; Lee J; Yi J; Chung YR.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
2/6 Transparent
Clinical characteristics of patients with epiretinal membrane-Foveoschisis.
Hetzel A; Neubauer J; Gelisken F.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Tissue-engineered anterior segment eye cultures demonstrate hallmarks of conventional organ culture.
Waxman S; Strzalkowska A; Wang C; Loewen R; Dang Y; Loewen NA.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
See clearer: survey on the subjective and objective information levels as well as perception and information transfer u…
Enders C; Duncker T; Schürks M; Scholz P; Dörner J; Müller C; Wachtlin J; Lommatzsch A.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Future perspectives for treating patients with geographic atrophy.
Loewenstein A; Trivizki O.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
A randomised controlled trial evaluating internal limiting membrane peeling forceps in macular hole surgery.
Ferrara M; Rivera-Real A; Hillier RJ; Habib M; Kadhim MR; Sandinha MT; Curran K; Muldrew A; Steel DHW.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Microvascular anastomosis of the human lacrimal gland: a concept study towards transplantation of the human lacrimal gl…
Holtmann C; Roth M; Filler T; Bergmann AK; Hänggi D; Muhammad S; Borrelli M; Geerling G.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The usefulness of lutein/trypan blue vital dye for the staining of corneal endothelium: a pilot study on DMEK pretreate…
Gisoldi RC; Lodato G; Balzamino BO; Esposito G; Micera A; Pocobelli A.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Antiplatelet and anticoagulant therapy in patients with submacular hemorrhage caused by neovascular age-related macular…
Weber C; Bertelsmann M; Kiy Z; Stasik I; Holz FG; Liegl R.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Sutureless versus conventional deep sclerectomy for management of open angle glaucoma.
Kotb MS; El Gharbawy SA; Abdelrahman AM; Makled HS.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Five-year follow-up of corneal endothelial cell density after transscleral ab interno glaucoma gel stent implantation.
Lenzhofer M; Motaabbed A; Colvin HP; Hohensinn M; Steiner V; Hitzl W; Runge C; Moussa S; Reitsamer HA.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Efficacy of selective laser trabeculoplasty on lowering intraocular pressure fluctuations and nocturnal peak intraocula…
Pillunat KR; Kocket GA; Herber R; Jasper CS; Lenk J; Pillunat LE.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Effect of low-dose atropine eyedrops on pupil metrics: results after half a year of treatment and cessation.
Bai WL; Gan JH; Wei S; Li SM; An WZ; Liang XT; Tian JX; Yin L; Wang N.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Final 4-year results of the RAINBOW real-world study: intravitreal aflibercept dosing regimens in France in treatment-n…
Cohen SY; Dominguez M; Coscas F; Faure C; Baillif S; Oubraham H; Kodjikian L; Weber M; RAINBOW study investigators.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Reliability analysis of successive Corvis ST® measurements in keratoconus 2 years after accelerated corneal crosslinkin…
Xanthopoulou K; Seitz B; Belin MW; Flockerzi E.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared